Nephros (NEPH) Net Income towards Common Stockholders (QoQ) (2010 - 2026)
Nephros (NEPH) Net Income towards Common Stockholders (QoQ) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 126.32 Bn | 121.10 Bn | 1.96 Bn |
| 2 | Becton Dickinson | 44.69 Bn | 43.88 Bn | 2.15 Bn |
| 3 | Alcon | 32.80 Bn | 31.14 Bn | 1.53 Bn |
| 4 | Medline | 32.72 Bn | 30.49 Bn | 1.84 Bn |
| 5 | Resmed | 29.54 Bn | 27.88 Bn | 890.98 Mn |
| 6 | West Pharmaceutical Services | 23.56 Bn | 23.13 Bn | 329.20 Mn |
| 7 | Solventum | 14.00 Bn | 13.44 Bn | 1.10 Bn |
| 8 | Cooper Companies | 13.75 Bn | 13.61 Bn | 735.40 Mn |
| 9 | Align Technology | 12.03 Bn | 10.97 Bn | 736.59 Mn |
| 10 | Nephros | 36.20 Mn | 32.18 Mn | 2.99 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -53.23% |
| Dec 31, 2025 | -81.60% |
| Sep 30, 2025 | 42.19% |
| Jun 30, 2025 | 126.36% |
| Mar 31, 2025 | -346.98% |
| Dec 31, 2024 | 98.91% |
| Sep 30, 2024 | 163.32% |
| Jun 30, 2024 | -38.94% |
| Mar 31, 2024 | 68.20% |
| Dec 31, 2023 | -259.34% |
| Sep 30, 2023 | 57.97% |
| Jun 30, 2023 | -41.50% |
| Mar 31, 2023 | 66.67% |
| Dec 31, 2022 | 71.59% |
| Sep 30, 2022 | -168.58% |
| Jun 30, 2022 | 40.74% |
| Mar 31, 2022 | -84.04% |
| Dec 31, 2021 | 9.74% |
| Sep 30, 2021 | -3.04% |
| Jun 30, 2021 | -98.99% |